Rad

Elastography

search

Elastography, Vibration-Controlled Transient Elastography, Fibroscan, Magnetic Resonance Elastography, MR Elastography

  • Indications
  1. Second-Line study for evaluation of MASLD or other Chronic Liver Disease related Liver Fibrosis
    1. May avert need for invasive testing (e.g. liver biopsy)
  2. Confirmation or first-line study with intermediate to high probability of fibrosis
    1. Fibrosis Probability Score
    2. NAFLD Fibrosis Score
  1. Recent meal
    1. May transiently increase liver stiffness
    2. Patient should fast 3 hours before study
  2. Acute liver inflammation
    1. Liver transaminases >5x normal
  3. Recent Alcohol use
  4. Right-sided Heart Failure
  5. Severe Obesity (BMI >40 kg/m2)
  • Imaging
  • Magnetic Resonance Elastography (MR Elastography, MRE)
  1. Most accurate for measuring Liver Fibrosis
  2. Preferred if BMI >36.65 kg/m2
  3. MR Elastography (MRE) score > 3.62 kPa is suggestive of advanced fibrosis
    1. MRE < 2.5 kPa: Normal (F0)
    2. MRE 2.5 to 3.5 kPa: Mild to moderate fibrosis (F1 to F2)
    3. MRE 3.5 to 4.0 kPa: Moderate to bridging fibrosis (F2 to F3)
    4. MRE 4.0 - 5.0 kPa: Advanced bridging fibrosis (F3 to F4)
    5. MRE = 5.0 kPa: Cirrhosis (F4)
  4. Tertiary Center Imaging Biomarkers (e.g. proton density fat fraction, iron corrected T1 mapping)
    1. Consider when other results are inconclusive for significant Hepatic Fibrosis
  • Imaging
  • Vibration-Controlled Transient Elastography (Fibroscan)
  1. MR Elastography is preferred for accuracy (but is less available and much higher cost)
    1. Fibroscan cost is estimated at $35
  2. Imaging study with high sensitivity for even mild Liver Fibrosis
    1. May be limited by operator experience and morbidly obese
    2. Highest accuracy in advanced fibrosis (stage F3) or Cirrhosis (stage F4)
    3. Most useful in excluding advanced fibrosis or Cirrhosis
  3. Fibroscan > 9.9 kPa is suggestive of advanced fibrosis
    1. Low Risk <8 kPa
    2. Intermediate risk 8-12 kPa
    3. High risk >12 kPa
  4. References
    1. Myers (2012) Hepatology 55(1): 199-208 [PubMed]